Education
About Us
Working with TipRanks
Follow Us
Tonix Pharmaceuticals (TNXP)
:TNXP
Tonix Pharma (TNXP) Ownership Overview
0.05% Insiders
0.27% Mutual Funds
0.69% Other Institutional Investors
1.21% ETFs
97.77% Public Companies and Individual Investors
The ownership structure of Tonix Pharma (TNXP) stock is a mix of institutional, retail, and individual investors. Approximately 2.17% of the company’s stock is owned by Institutional Investors, 0.05% is owned by Insiders, and 97.77% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 15, 2025 | xxxxxxxxxxxxx | $86200 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 88,856 | Institution | 1.21% | 2,052,574 | |
| 19,482 | Institution | 0.27% | 450,034 | |
| 4,007 | Insider | 0.05% | 92,562 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 19,482 | Institution | 0.27% | 450,034 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 88,856 | Institution | 1.21% | 1,600,297 |
FAQ
Who Owns Tonix Pharmaceuticals (TNXP)?
According to the latest TipRanks data, approximately 0.69% of the company's stock is held by institutional investors, 0.05% is held by insiders, and 97.77% is held by retail investors.
What percentage of Tonix Pharmaceuticals (TNXP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.69% of Tonix Pharmaceuticals (TNXP) stock is held by institutional investors.
What percentage of Tonix Pharmaceuticals (TNXP) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.77% of Tonix Pharmaceuticals (TNXP) stock is held by retail investors.
Who owns the most shares of Tonix Pharmaceuticals (TNXP)?
Vanguard owns the most shares of Tonix Pharmaceuticals (TNXP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.